Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Disease Models & Mechanisms
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Disease Models & Mechanisms

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
RESEARCH ARTICLE
Molecular characterization of hepatocarcinogenesis using mouse models
Wei Wei Teoh, Min Xie, Aadhitthya Vijayaraghavan, Jadegoud Yaligar, Wei Min Tong, Liang Kee Goh, Kanaga Sabapathy
Disease Models & Mechanisms 2015 8: 743-753; doi: 10.1242/dmm.017624
Wei Wei Teoh
1Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 11 Hospital Drive, 169610, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Xie
1Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 11 Hospital Drive, 169610, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aadhitthya Vijayaraghavan
2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jadegoud Yaligar
3Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, 11 Biopolis Way, Helios, 138667, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Min Tong
4Institute of Basic Medical Sciences School of Basic Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College 5, Dong Dan San Tiao, Beijing 100005, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang Kee Goh
2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kanaga Sabapathy
1Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 11 Hospital Drive, 169610, Singapore
2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore
5Department of Biochemistry, National University of Singapore, 8 Medical Drive, 117597, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cmrksb@nccs.com.sg
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Experimental set-up and characterization of liver nodules. (A) Schematic showing the time points of mice collection as well as injections of either corn oil (as control) or AFB1, into the various groups of mice. In the first group, 7-day-old (D7) mice were injected and the cohorts were collected at 3-month intervals over 15 months. In the adult group, 6- or 12-month-old (6 M or 12 M) mice were injected and collected at 3-month intervals until 15 months of age. (B) Work flow upon sacrifice of mice at collection. All organs were harvested and fixed for histological analysis by H&E staining. The liver was separated into nine parts, in triplicates, for DNA, RNA and protein isolation, in addition to the histological analysis. Liver nodules were separated from normal livers and collected similarly. Serum was obtained via blood collected through heart puncture upon sacrifice of the animals. (C,D) Liver samples were photographed prior to dissection at each stage of collection [shown as months (M)]. C shows livers from the various mice cohorts that were AFB1/corn oil-injected at D7. D shows adult mice when injected at 6 M (left) or 12 M (right). Representative pictures are shown.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Characterization of susceptibility based on age and gender. (A,B) Liver samples were scored as described in the text, and the data are represented as number of liver nodules (≥0.5 cm) per mouse, over the time course of collection in the various groups of mice (top panel). The bottom panel shows the size of these liver nodules in the various categories of mice. Nodules <0.5 cm were scored as 0.2 cm for ease of enumeration, and were counted in this case. Data for mice injected at D7 (A) and 6 M or 12 M (B) are shown. Each dot represents a single mouse (top) or nodule (bottom). Horizontal bars represent average numbers of nodules (top panel). (C,D) Effect of gender on liver nodule development was determined by scoring the percentage of male or female mice with nodules (0.2 cm and above) at the various time points of collections, after injection at D7 (C) or at 6 M (D). *P≤0.05; ns, not significant.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Histological analysis of liver sections. (A-D) Liver samples were H&E-stained and analyzed by photomicrography from the various categories of mice injected at D7, at the different time points of collection. Representative pictures from at least six independent mice for each time point/category are shown. Liver tumors from each case, at 15 M of age, are shown in the last image of B-D (denoted by ‘Tumor - 15’). (E) Comparison of mouse liver nodules at 15 M with human HCC and adenoma.

  • Table 1.
  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Genomic characteristics of mouse HCC model. (A) Transcriptome profiling of normal livers and liver nodules from the various groups were performed by Affymetrix mouse arrays. PCA, shown in the left panel, revealed distinct clustering of tumor and normal samples, with adjacent normal clustered between tumor and normal samples. Each data point represents one sample and the ellipsoids represent the zone within 2 s.d. of each experimental group. Right panel shows the heat map of unsupervised hierarchical clustering based on probes with s.d.≥1, which reveals distinct clustering of tumor and normal samples. Within the tumor group, differential clustering was also observed based on genotype. Treatment parameters are indicated on the sides. (B) Heat map of 11 genes found to be differentially expressed between HBsAg_Oil_T and HBsAg_Oil_N in the mouse HCC model. Distinct clustering was observed as expected between tumor and normal samples, based on the expression pattern of these genes. Seven genes (underlined) could be mapped to human microarray chips.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    HCC-specific gene expression signature. (A,B) Differential clustering between tumor and normal samples was observed when segregated by the HCC gene expression signature, similar to the mouse HCC model. (C,D) Heat map of unsupervised clustering based on the gene signature in human breast cancers (C) or colon cancers (D) showed less differential clustering of tumor and normal samples. (E) Summary of SVM model analysis of sensitivity of the gene expression signature to identify the human tumor types.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Molecular characterization of liver nodules from mouse models. (A,B) Venn diagram showing the genes (A) or upstream regulators (B) affected in the liver tumors in each of the categories and their overlap. The top five upstream regulators are highlighted on the sides. Numbers in parentheses indicate the genes/regulators identified through the differential gene expression. (C) Top canonical pathways involving the upstream regulators in the tumors from the various categories are listed. (D) Venn diagram showing upstream regulators perturbed in human HCCs and HBsAg_AFB_T versus WT_Oil_N.

Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Aflatoxin B1
  • Hepatitis B surface antigen
  • Hepatocellular carcinoma
  • Mouse models

 Download PDF

Email

Thank you for your interest in spreading the word on Disease Models & Mechanisms.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular characterization of hepatocarcinogenesis using mouse models
(Your Name) has sent you a message from Disease Models & Mechanisms
(Your Name) thought you would like to see the Disease Models & Mechanisms web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
RESEARCH ARTICLE
Molecular characterization of hepatocarcinogenesis using mouse models
Wei Wei Teoh, Min Xie, Aadhitthya Vijayaraghavan, Jadegoud Yaligar, Wei Min Tong, Liang Kee Goh, Kanaga Sabapathy
Disease Models & Mechanisms 2015 8: 743-753; doi: 10.1242/dmm.017624
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
RESEARCH ARTICLE
Molecular characterization of hepatocarcinogenesis using mouse models
Wei Wei Teoh, Min Xie, Aadhitthya Vijayaraghavan, Jadegoud Yaligar, Wei Min Tong, Liang Kee Goh, Kanaga Sabapathy
Disease Models & Mechanisms 2015 8: 743-753; doi: 10.1242/dmm.017624

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • Mutant Cx30-A88V mice exhibit hydrocephaly and sex-dependent behavioral abnormalities, implicating a functional role for Cx30 in the brain
  • Resolving the heterogeneity of diaphragmatic mesenchyme: a novel mouse model of congenital diaphragmatic hernia
  • Interpreting the pathogenicity of Joubert syndrome missense variants in Caenorhabditis elegans
Show more RESEARCH ARTICLE

Similar articles

Subject collections

  • Cancer

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Biology Open

Advertisement

DMM and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


Professor Elizabeth Patton appointed as DMM’s next Editor-in-Chief

We are pleased to announce that The Company of Biologists directors have appointed Professor Elizabeth Patton as DMM's new Editor-in-Chief. As Paresh Vyas writes in his Editorial, Liz ‘brings vitality and a passion for the remit of DMM, and is deeply embedded in the community.’


Did you know DMM Conference Travel Grants can be used for online meetings?

With travel restrictions still in place, we want to continue supporting early-career researchers in their careers. DMM’s Conference Travel Grants can now be used to attend virtual and online scientific meetings, workshops, conferences and training courses.

The current application round closes on 8 February 2021 – find out more.


Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart

Research from Silke Sperling and colleagues uses Drosophila to identify MYOM2 as a candidate gene in congenital heart malformations in this issue’s Editor’s choice.


C. elegans as a disease model

A new Research article from Doyle et al., models spinal muscular atrophy in C. elegans to show that that targeting therapies to muscle cells is more effective than neuronal delivery. Find more research using C. elegans as a disease model in our latest subject collection.


Call for papers – The RAS Pathway: Diseases, Therapeutics and Beyond

Our upcoming special issue is now welcoming submissions until 1 April 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on the targeting the RAS pathway. Find out more about the issue and how to submit your manuscript.


Interview – Kim Landry-Truchon and Nicolas Houde

In an interview, first authors Kim Landry-Truchon and Nicolas Houde discuss their mouse model of the early stages of pleuropulmonary blastoma, reflecting on the implications of their work and the future of their field.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About DMM
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact DMM
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992